JPS62234054A - ３−フエノキシ（またはフエニルチオ）シクロペンタンカルボニルアミノ酸誘導体およびそれらを有効成分として含有する脳浮腫治療剤 - Google Patents

３−フエノキシ（またはフエニルチオ）シクロペンタンカルボニルアミノ酸誘導体およびそれらを有効成分として含有する脳浮腫治療剤

Info

Publication number
JPS62234054A
JPS62234054A JP61291609A JP29160986A JPS62234054A JP S62234054 A JPS62234054 A JP S62234054A JP 61291609 A JP61291609 A JP 61291609A JP 29160986 A JP29160986 A JP 29160986A JP S62234054 A JPS62234054 A JP S62234054A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
dichloro
cyclopentanecarbonyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP61291609A
Other languages
English (en)
Japanese (ja)
Other versions
JPH053870B2 (2
Inventor
Katsuhiro Imaki
今木　勝広
Tadao Okegawa
桶川　忠夫
Yoshinobu Arai
義信 新井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ono Pharmaceutical Co Ltd
Original Assignee
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co Ltd filed Critical Ono Pharmaceutical Co Ltd
Publication of JPS62234054A publication Critical patent/JPS62234054A/ja
Publication of JPH053870B2 publication Critical patent/JPH053870B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
JP61291609A 1985-12-16 1986-12-09 ３−フエノキシ（またはフエニルチオ）シクロペンタンカルボニルアミノ酸誘導体およびそれらを有効成分として含有する脳浮腫治療剤 Granted JPS62234054A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60-281203 1985-12-16
JP28120385 1985-12-16

Publications (2)

Publication Number Publication Date
JPS62234054A true JPS62234054A (ja) 1987-10-14
JPH053870B2 JPH053870B2 (2) 1993-01-18

Family

ID=17635786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61291609A Granted JPS62234054A (ja) 1985-12-16 1986-12-09 ３−フエノキシ（またはフエニルチオ）シクロペンタンカルボニルアミノ酸誘導体およびそれらを有効成分として含有する脳浮腫治療剤

Country Status (7)

Country Link
US (4) US4783476A (2)
EP (1) EP0231619B1 (2)
JP (1) JPS62234054A (2)
AT (1) ATE61343T1 (2)
DE (1) DE3677954D1 (2)
ES (1) ES2029796T3 (2)
GR (1) GR3001971T3 (2)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206883B (en) * 1990-12-18 1993-01-28 Richter Gedeon Vegyeszet Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them
KR970029416A (ko) * 1995-11-30 1997-06-26 김광호 광픽업용 대물렌즈 구동장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791201A (fr) * 1971-11-12 1973-05-10 Merck & Co Inc Indanyloxytetrazoles
US3984465A (en) * 1972-10-13 1976-10-05 Merck & Co., Inc. 1-Oxo-2,2-disubstituted-5-indanyloxy(or thio)alkanoic acids
US4012524A (en) * 1973-10-12 1977-03-15 Merck & Co., Inc. [1-Hydroxy-5-indanyloxy (or thio)]-alkanoic acids
PL98342B1 (pl) * 1974-07-30 1978-04-29 Sposob wytwarzania kwasu 1-keto-2-arylo-/lub tienylo/-2-podstawionego-indanyloksy-/lub tio/-5-alkanokarboksylowego
US4197309A (en) * 1976-10-12 1980-04-08 Albert Roland S.A. 4-Keto-phenoxyacetic acids
JPS53124260A (en) * 1977-04-06 1978-10-30 Takeda Chem Ind Ltd Indan derivatives
US4166061A (en) * 1977-11-02 1979-08-28 Smithkline Corporation Use of cyclic esters to prepare 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid
JPS61103850A (ja) * 1984-10-29 1986-05-22 Ono Pharmaceut Co Ltd ３−（インダン−５−イルオキシ（またはチオ））シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する治療剤

Also Published As

Publication number Publication date
US4783476A (en) 1988-11-08
ATE61343T1 (de) 1991-03-15
US5023268A (en) 1991-06-11
ES2029796T3 (es) 1992-10-01
JPH053870B2 (2) 1993-01-18
GR3001971T3 (en) 1992-11-23
US4888351A (en) 1989-12-19
US4829078A (en) 1989-05-09
EP0231619B1 (en) 1991-03-06
EP0231619A3 (en) 1988-01-27
DE3677954D1 (de) 1991-04-11
EP0231619A2 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
JP3121343B2 (ja) ポリ―４―アミノ―２―カルボキシ―１―メチル化合物の新規ウレイド誘導体
EP0079872B1 (en) Antifibrinolytically active compounds
JPH0550516B2 (2)
US7915303B2 (en) Glycopyrronium salts and their therapeutic use
JPH0395154A (ja) ［ジ―ｔｅｒｔ―ブチル（ヒドロキシ）フェニルチオ］置換ヒドロキサム酸誘導体
JPH0211579B2 (2)
JP2691679B2 (ja) オキシム誘導体およびそれを含有する医薬品
EP0109866B1 (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
JPS63264454A (ja) 新規なプロリナール誘導体
US20080234258A1 (en) Dihydroxyanthraquinones and Their Use
CN1036714C (zh) 晶状的碳代青霉烯衍生物
DE3882795T2 (de) Bicyclische Sulfonamidderivate, ihre Herstellung, ihre Anwendung und Zubereitungen die sie enthalten.
EP1016646A1 (fr) Nouveaux produits intermédiaires pour la préparation de céphalosporines comportant en position 7 un radical benzyloxyimino substitué
JPS62234054A (ja) ３−フエノキシ（またはフエニルチオ）シクロペンタンカルボニルアミノ酸誘導体およびそれらを有効成分として含有する脳浮腫治療剤
WO2005084658A1 (en) Derivatives of actarit and their therapeutic use
JPS63190870A (ja) 抗菌活性を有する化合物、その製造法及びそれを含む医薬製剤
JPH06172287A (ja) アミノカルボン酸誘導体及び該化合物を含有する医薬組成物
US6750250B1 (en) 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
JPS6219552A (ja) ３−〔（４−アロイル）フエノキシ（またはフエニルチオ）〕シクロペンタンカルボン酸誘導体、それらの製造方法及びそれらを有効成分として含有する脳浮腫治療剤
HU180103B (en) Process for producing analogues of 9,11,15-trideoxy-prostaglandine-f
JPS6160816B2 (2)
CA1095039A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
JPH0118916B2 (2)
JPH0676379B2 (ja) 糖ラクタム誘導体及びそれを含有する抗炎症剤
JPH03223244A (ja) ５―ヘテロ―６―オキソ―ｐｇｅ誘導体、それらの製造方法およびそれらを含有する薬剤